Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: An economic modelling study
The Lancet HIV Jun 04, 2019
Haakenstad A, et al. - Considering the importance of domestic financing for supporting the response to HIV/AIDS in light of a 20% decrease in development assistance for HIV/AIDS between 2012 and 2016, researchers tracked spending on HIV/AIDS and assessed if governments could give additional domestic funds to HIV/AIDS response and if the financing gaps created by declines in development assistance could be filled by domestic resources. Analyzing 8,589 datapoints reporting spending on HIV/AIDS, they noted spending of $19.9 billion (15.8–26.3) on HIV/AIDS in 2016 across all low-income and middle-income countries. Of which $3.0 billion (1.5–5.8) was spent on prevention and $7.2 billion (4.3–11.8) on care and treatment. Prevention spending per prevalent case and spending on care and treatment per year on antiretroviral therapy varied substantially: high-prevalence countries like Mozambique and South Africa spent less than $40 on prevention spending per prevalent case of HIV/AIDS; Ethiopia spent more than $110 on prevention per prevalent case. As per estimations, it seems that more domestic resources could be mobilized by some governments to fight HIV/AIDS. This may release additional development assistance for many countries that can’t, including many low-income, high-prevalence countries. There is a large gap, however, between available financing and the funds required to reach global HIV/AIDS goals. To end AIDS by 2030, a continuous and coordinated effort across international and domestic development partners is needed.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries